Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2025-12-24 @ 10:47 PM
NCT ID:
NCT00469469
Brief Title:
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Official Title:
A Phase II Study of Bevacizumab in Patients With Nonresectable Cancer of the Adrenal Cortex.
Study:
NCT00469469
Protocol Section:
NCT00469469